Clinical
RSSArticles
-
Biventricular Hypertrophy in an Asymptomatic Patient?
-
Eravacycline Injection (Xerava)
The FDA has approved a new parenteral, broad-spectrum antibiotic in the tetracycline class for the treatment of complicated intra-abdominal infections.
-
Home-based Detection of Undiagnosed Atrial Fibrillation
In patients with risk factors for atrial fibrillation, screening with a self-applied wearable ECG patch resulted in significantly increased rates of new atrial fibrillation diagnoses within four months, along with greater use of anticoagulants and healthcare resources.
-
Are In-hospital Deaths Related to Community-acquired Pneumonia Preventable?
This secondary analysis of data from five tertiary care centers found that among patients hospitalized for community-acquired pneumonia, very few deaths potentially were related to a lapse in in-hospital quality of pneumonia care.
-
Revised Anticoagulation Therapy Guidelines for Atrial Fibrillation Patients
More patients with atrial fibrillation may receive anticoagulation, according to new recommendations.
-
Conservatives Work to Bar Private Coverage of Abortion
-
Safety Warning Issued for Fluoroquinolone Antibiotics
The federal Food and Drug Administration (FDA) now is asking clinicians to consider other treatment options besides fluoroquinolone antibiotics because of risks associated with their use.
-
More Teens Are Up to Date on HPV Shot
Just-released data indicate human papillomavirus (HPV) vaccination completion in U.S. adolescents increased by five percentage points from 2016 to 2017, and initiation of the vaccine has gone up 5.1 percentage points, on average, each year since 2013.
-
Barriers Still Exist for Teen Access to Emergency Contraception
Even though age limits for purchasing emergency contraception (EC) were removed five years ago, results of a recent survey of more than 700 Texas pharmacies found that 46.5% of drugstores still have an age restriction for buying the medication, and more than 50% require a consultation before medication purchase.
-
USPSTF Issues Final Guidance for Cervical Cancer Screening
The US Preventive Services Task Force has issued final recommendations for cervical cancer screening, calling for women ages 21 to 29 to be tested with cervical cytology every three years.